Bill Text: VA HB1409 | 2023 | Regular Session | Chaptered


Bill Title: Drug Control act; distribution of hypodermic needles.

Spectrum: Bipartisan Bill

Status: (Passed) 2023-03-21 - Governor: Acts of Assembly Chapter text (CHAP0142) [HB1409 Detail]

Download: Virginia-2023-HB1409-Chaptered.html

CHAPTER 142
An Act to amend and reenact §54.1-3467 of the Code of Virginia, relating to Drug Control Act; prohibition of distribution of hypodermic needles; exception.
[H 1409]
Approved March 21, 2023

 

Be it enacted by the General Assembly of Virginia:

1. That §54.1-3467 of the Code of Virginia is amended and reenacted as follows:

§54.1-3467. Distribution of hypodermic needles or syringes, gelatin capsules, quinine or any of its salts.

A. Distribution by any method, of any hypodermic needles or syringes, gelatin capsules, quinine or any of its salts, in excess of one-fourth ounce shall be restricted to licensed pharmacists or to others who have received a license or a permit from the Board.

B. Nothing in this section shall prohibit the dispensing or distributing of hypodermic needles and syringes by persons authorized by the State Health Commissioner pursuant to a comprehensive harm reduction program established pursuant to §32.1-45.4 who are acting in accordance with the standards and protocols of such program for the duration of the declared public health emergency.

C. Nothing in this section shall prohibit the dispensing or distributing of hypodermic needles and syringes by persons authorized to dispense naloxone in accordance with the provisions of subsection Y of §54.1-3408 and who, in conjunction with such dispensing of naloxone, dispenses or distributes hypodermic needles and syringes. Nothing in this section shall prohibit the dispensing of hypodermic needles and syringes for the administration of prescribed drugs by prescribers licensed to dispense Schedule VI controlled substances at a nonprofit facility pursuant to §54.1-3304.1.

D. Notwithstanding the provisions of subsection A, nothing in this section shall prohibit the distribution of hypodermic needles that are designed to be used with a reusable injector pen for the administration of insulin.

feedback